The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Robert F. Kennedy Jr. would have broad power as HHS secretary to strip vaccine makers' protections against lawsuits ...

SHOPPING: If you're ready to take control of your weight loss goals, turn to Get Thin MD for prescription GLP-1 medications ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...